Familial partial lipodystrophy associated with PPARG mutations (Q97029): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / CURIE
 
CID11:ID_2042807932
Property / CURIE: CID11:ID_2042807932 / rank
 
Normal rank

Revision as of 13:03, 16 August 2026

Familial partial lipodystrophy associated with PPARG (peroxisome proliferative activated receptor gamma) mutations belongs to the group of lipodystrophy syndromes characterised by anomalies of adipose tissue distribution and often associated with severe insulin resistance manifested by hyperinsulinaemia (insulin levels above 20mUI/l), carbohydrate intolerance or diabetes, hypertriglyceridaemia with low levels of high-density lipoproteins (HDL) and arterial hypertension. Acanthosis nigricans, hepatic steatosis and polycystic ovary syndrome are also frequent.
Language Label Description Also known as
default for all languages
ID_2042807932
    English
    Familial partial lipodystrophy associated with PPARG mutations
    Familial partial lipodystrophy associated with PPARG (peroxisome proliferative activated receptor gamma) mutations belongs to the group of lipodystrophy syndromes characterised by anomalies of adipose tissue distribution and often associated with severe insulin resistance manifested by hyperinsulinaemia (insulin levels above 20mUI/l), carbohydrate intolerance or diabetes, hypertriglyceridaemia with low levels of high-density lipoproteins (HDL) and arterial hypertension. Acanthosis nigricans, hepatic steatosis and polycystic ovary syndrome are also frequent.

      Statements

      CID11:ID_2042807932
      0 references